"We consider this price reduction to be a big feat,” said Brenda Waning, who hea...
A new suggests that patients treated by female surgeons have lower rates of adve...
On Tuesday, the U.S. government named 10 medicines that will be subject to Medic...
Thousands of patients are stuck on waiting lists for the new Alzheimer's therapy...
In virtual writing workshops, Laurel Braitman has created a place where health c...
“This is the saga of the pharmaceutical industry. One or two drugs are approved ...
A new understanding of the butterfly effect has changed how one inpatient child ...
Alvotech and Bioventure received the Egyptian Drug Authority's approval to produ...
Ipilimumab is under clinical development by Bristol-Myers Squibb and currently i...
Shares in the company tanked 80% following the FDA issued a CRL for its bevacizu...
Codagenix faces a late 2024 data readout following enrollment challenges in its ...
The subcutaneous Tecentriq has been approved in the UK for all indications that ...
The $1.5bn deal is the largest the newly formed company have performed yet, but ...
The US FDA has granted priority review for Zealand Pharma’s dasiglucagon for hyp...
The Phase III trial for FibroGen’s antibody candidate failed to meet its primary...
Biostax and Immgenuity have entered into an agreement to expedite the developmen...
